Aetiologic heterogeneity in pediatric Hodgkin lymphoma? Evidence from the Nordic countries, 1978–2010

Abstract

Background. In epidemiological studies, Hodgkin lymphomas (HL) in children younger than 15 years and HL in adolescents and younger adults age 15–35 years has traditionally been studied separately, under the assumption that HL at age 0–14 constitute a homogeneous entity. However, the continued validity of this research practice in affluent settings may be questioned. Specifically, the boundary at age 15 years may not be epidemiologically justified, and therefore also questionable clinically. We therefore updated and further characterised recent HL incidence patterns among Nordic children.

Material and methods. We obtained HL incidence data in children aged 0–14 years for the period 1978–2010 from the five nationwide Nordic cancer registries. The data were analysed by log-linear and/or a mixture of Poisson regression models.

Results. The analyses showed statistically significantly decreasing and increasing HL incidence rates in children younger and older than eight years, respectively during the study period. Statistical modelling suggested that cases in children age 0–6 years constituted a disease entity of its own, whereas cases in older children were more likely to belong to the younger adult HL entity.

Conclusion. Diverging incidence trends and statistical modelling suggest that HL in children age 0–14 years cannot be assumed to constitute a homogeneous disease entity in affluent settings.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.